| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8958332 | Journal of Minimally Invasive Gynecology | 2018 | 10 Pages |
Abstract
Both 200âµg and 400âµg vaginally administered misoprostol are effective for cervical dilatation, and we recommend vaginal administration of 200âµg misoprostol for cervical dilatation 8 hours before operative hysteroscopy because of lower adverse events in the 200-µg group as well as similar efficacy between cohorts.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ji Young MD, Seung Hun MD,